Hummingbird

Investment area

Venture Investments

Region

Asia

Date of investment

April 2021

Hummingbird Bioscience is an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets to improve treatment outcomes.

Visit site